Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - nilotinib hcl monohydrate 165.45mg eqv nilotinib - capsule - 150mg - nilotinib hcl monohydrate 165.45mg eqv nilotinib 150mg

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - aspirin,dipyridamole -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

boehringer ingelheim ltd - dipyridamole; aspirin - modified-release capsule - 200mg ; 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - dipyridamole; aspirin - modified-release capsule - 200mg ; 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk) ltd - dipyridamole; aspirin - modified-release capsule - 200mg ; 25mg

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - indapamide hemihydrate 2.5mg - tablet - 2.5 mg - active: indapamide hemihydrate 2.5mg excipient: croscarmellose sodium lactose magnesium stearate microcrystalline cellulose opadry pink oy-6953 purified water sodium starch glycolate - essential hypertension. it may be tried as a sole therapeutic agent in the treatment of mild to moderate hypertension. normally indapamide is used as the initial agent in multiple drug regimens.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - pentoxifylline 400mg;  ;   - modified release tablet - 400 mg - active: pentoxifylline 400mg     excipient: erythrosine hyetellose hypromellose macrogol 8000 magnesium stearate povidone purified talc   purified water   titanium dioxide - the treatment of peripheral occlusive vascular disease and circulatory disorders of arteriosclerotic, diabetic, inflammatory or function origin; trophic disorders (e.g., leg ulcers and gangrene).

European Union - English - EMA (European Medicines Agency)

bayer ag - iloprost - hypertension, pulmonary - antithrombotic agents - treatment of patients with primary pulmonary hypertension, classified as new york heart association functional class iii, to improve exercise capacity and symptoms.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; colloidal anhydrous silica; hypromellose; macrogol 3350; titanium dioxide; purified talc; polyvinyl alcohol - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, indapamide is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: titanium dioxide; macrogol 6000; hypromellose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica; glycerol; povidone - treatment of hypertension. it may be tried as a sole therapeutic agent in the treatment of hypertension. normally, ardix indapamide sr is used as the initial agent in multiple drug regimes.